These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32390334)

  • 1. CompoundDB4j: Integrated Drug Resource of Heterogeneous Chemical Databases.
    Murali V; Königs C; Deekshitula S; Nukala S; Santhi MD; Athri P
    Mol Inform; 2020 Sep; 39(9):e2000013. PubMed ID: 32390334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPDMs-a resource for mapping small molecule bioactivities from ChEMBL to Pfam-A protein domains.
    Kruger FA; Gaulton A; Nowotka M; Overington JP
    Bioinformatics; 2015 Mar; 31(5):776-8. PubMed ID: 25348214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. myChEMBL: a virtual machine implementation of open data and cheminformatics tools.
    Ochoa R; Davies M; Papadatos G; Atkinson F; Overington JP
    Bioinformatics; 2014 Jan; 30(2):298-300. PubMed ID: 24262214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug target ontology to classify and integrate drug discovery data.
    Lin Y; Mehta S; Küçük-McGinty H; Turner JP; Vidovic D; Forlin M; Koleti A; Nguyen DT; Jensen LJ; Guha R; Mathias SL; Ursu O; Stathias V; Duan J; Nabizadeh N; Chung C; Mader C; Visser U; Yang JJ; Bologa CG; Oprea TI; Schürer SC
    J Biomed Semantics; 2017 Nov; 8(1):50. PubMed ID: 29122012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ChEMBL web services: streamlining access to drug discovery data and utilities.
    Davies M; Nowotka M; Papadatos G; Dedman N; Gaulton A; Atkinson F; Bellis L; Overington JP
    Nucleic Acids Res; 2015 Jul; 43(W1):W612-20. PubMed ID: 25883136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping between databases of compounds and protein targets.
    Muresan S; Sitzmann M; Southan C
    Methods Mol Biol; 2012; 910():145-64. PubMed ID: 22821596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enalos Suite: New Cheminformatics Platform for Drug Discovery and Computational Toxicology.
    Varsou DD; Nikolakopoulos S; Tsoumanis A; Melagraki G; Afantitis A
    Methods Mol Biol; 2018; 1800():287-311. PubMed ID: 29934899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using DrugBank for In Silico Drug Exploration and Discovery.
    Wishart DS; Wu A
    Curr Protoc Bioinformatics; 2016 Jun; 54():14.4.1-14.4.31. PubMed ID: 27322405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic integration of biomedical knowledge prioritizes drugs for repurposing.
    Himmelstein DS; Lizee A; Hessler C; Brueggeman L; Chen SL; Hadley D; Green A; Khankhanian P; Baranzini SE
    Elife; 2017 Sep; 6():. PubMed ID: 28936969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heterogeneous pharmacological medical biochemical network PharMeBINet.
    Königs C; Friedrichs M; Dietrich T
    Sci Data; 2022 Jul; 9(1):393. PubMed ID: 35821017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery.
    Nowotka MM; Gaulton A; Mendez D; Bento AP; Hersey A; Leach A
    Expert Opin Drug Discov; 2017 Aug; 12(8):757-767. PubMed ID: 28602100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-source chemogenomic data-driven algorithms for predicting drug-target interactions.
    Hao M; Bryant SH; Wang Y
    Brief Bioinform; 2019 Jul; 20(4):1465-1474. PubMed ID: 29420684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDR Targets 6: driving drug discovery for human pathogens through intensive chemogenomic data integration.
    Urán Landaburu L; Berenstein AJ; Videla S; Maru P; Shanmugam D; Chernomoretz A; Agüero F
    Nucleic Acids Res; 2020 Jan; 48(D1):D992-D1005. PubMed ID: 31680154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing public domain data to discover and validate therapeutic targets.
    Reisdorf WC; Chhugani N; Sanseau P; Agarwal P
    Expert Opin Drug Discov; 2017 Jul; 12(7):687-693. PubMed ID: 28494630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting the most out of PubChem for virtual screening.
    Kim S
    Expert Opin Drug Discov; 2016 Sep; 11(9):843-55. PubMed ID: 27454129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
    Emon MA; Domingo-Fernández D; Hoyt CT; Hofmann-Apitius M
    BMC Bioinformatics; 2020 Jun; 21(1):231. PubMed ID: 32503412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ChEMBL bioactivity database: an update.
    Bento AP; Gaulton A; Hersey A; Bellis LJ; Chambers J; Davies M; Krüger FA; Light Y; Mak L; McGlinchey S; Nowotka M; Papadatos G; Santos R; Overington JP
    Nucleic Acids Res; 2014 Jan; 42(Database issue):D1083-90. PubMed ID: 24214965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Machine Learning Approach for Drug-target Interaction Prediction using Wrapper Feature Selection and Class Balancing.
    Redkar S; Mondal S; Joseph A; Hareesha KS
    Mol Inform; 2020 May; 39(5):e1900062. PubMed ID: 32003548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations.
    Mullen J; Cockell SJ; Woollard P; Wipat A
    PLoS One; 2016; 11(5):e0155811. PubMed ID: 27196054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding.
    Chen H; Cheng F; Li J
    PLoS Comput Biol; 2020 Jul; 16(7):e1008040. PubMed ID: 32667925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.